Bal Pharma Limited (BALPHARMA)
₹98.67
INR-0.27(-0.27%)
As of June 24, 2025 9:40:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹157.66 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹336.84 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
21.72
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
-2.82
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
0.52
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
46.29%
Operating Margin
Operating income as a percentage of revenue
6.67%
Return on Equity
Net income as a percentage of shareholders' equity
9.87%
Revenue (TTM)
Total revenue over trailing 12 months
₹303.08 Cr-13.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹31.76 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹4.56+23%
Balance Sheet
Total Cash
Total cash and short-term investments
₹10.52 Cr
Total Debt
Total short-term and long-term debt
₹150.41 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
194.32%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹78.06 - ₹157.98
Beta
Measure of stock's volatility compared to the market
0.20
Shares Outstanding
Total number of shares issued by the company
₹1.59 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.21%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
1.21%
Payout Ratio
Percentage of earnings paid as dividends
26.32%
